Literature DB >> 16294197

Reprogramming liver-stem WB cells into functional insulin-producing cells by persistent expression of Pdx1- and Pdx1-VP16 mediated by lentiviral vectors.

Dong-Qi Tang1, Shun Lu, Yu-Ping Sun, Enda Rodrigues, Wayne Chou, Cheryl Yang, Li-Zhen Cao, Lung-Ji Chang, Li-Jun Yang.   

Abstract

Adenovirus-mediated transient expression of the pancreatic duodenal homeobox transcription factor Pdx1 in mouse liver activates pancreatic endocrine and exocrine genes, the latter reportedly resulting in severe hepatitis. Expression of a super-active form of Pdx1 or Pdx1-VP16 selectively transdifferentiates hepatic WB cells into functional pancreatic beta-like insulin-producing cells, without evidence of exocrine differentiation. No study has systematically compared the transdifferentiation efficiency of Pdx1 and Pdx1-VP16 at the cellular and molecular level. Comparisons can be ambiguous when vectors harboring a transcription factor cDNA have differing extents and duration of gene expression. In view of the remarkable capacity of lentiviral vector (LV) for delivering and integrating transgene into both dividing and nondividing cells, we transduced rat hepatic stem cell-like WB cells with LV-Pdx1 or LV-Pdx1-VP16, and then used the limiting-dilution technique to clone single-cell-derived cell lines that stably express either Pdx1 or Pdx1-VP16. With these cell lines, we studied: (a) the expression of Pdx1 or Pdx1-VP16 protein by Western blotting and immunocytochemistry; (b) the repertoire of long-term expression of Pdx1- or Pdx1-VP16-induced pancreatic gene expression using RT-PCR methods; and (c) their capacity to serve as beta-cell surrogates in restoring euglycemia in streptozotocin-treated diabetic mice. We found that cell lines expressing either Pdx1 or Pdx1-VP16 long-term exhibited similar profiles for expression of genes related to pancreatic development and beta-cell function, and reversed hyperglycemia in diabetic mice. We also examined short-term expression of Pdx1 or Pdx1-VP16, and the results demonstrated that expression of Pdx1-VP16 is more efficient in initiating liver-to-endocrine pancreas transdifferentiation. Our findings demonstrate: (a) that the LV system is highly effective in producing persistent expression of Pdx1 or Pdx1-VP16 in WB hepatic cells; and (b) long-term, persistent expression of either Pdx1 or Pdx1-VP16 is similarly effective in converting hepatic stem cells into pancreatic endocrine precursor cells that, upon transplantation into diabetic mice, become functional insulin-producing cells and restore euglycemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16294197      PMCID: PMC3417286          DOI: 10.1038/labinvest.3700368

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  28 in total

1.  Lentiviral vectors. Preparation and use.

Authors:  Lung-Ji Chang; Anne-Kathrin Zaiss
Journal:  Methods Mol Med       Date:  2002

2.  Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells.

Authors:  V K Ramiya; M Maraist; K E Arfors; D A Schatz; A B Peck; J G Cornelius
Journal:  Nat Med       Date:  2000-03       Impact factor: 53.440

3.  Hematopoietic stem cell markers are expressed by ductal plate and bile duct cells in developing human liver.

Authors:  K Blakolmer; K Jaskiewicz; H A Dunsford; S C Robson
Journal:  Hepatology       Date:  1995-06       Impact factor: 17.425

4.  GAL4-VP16 is an unusually potent transcriptional activator.

Authors:  I Sadowski; J Ma; S Triezenberg; M Ptashne
Journal:  Nature       Date:  1988-10-06       Impact factor: 49.962

5.  In vitro differentiation of WB-F344 rat liver epithelial cells into the biliary lineage.

Authors:  Dominique Couchie; Nathalie Holic; Marie-Noële Chobert; Anne Corlu; Yannick Laperche
Journal:  Differentiation       Date:  2002-01       Impact factor: 3.880

6.  Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia.

Authors:  S Ferber; A Halkin; H Cohen; I Ber; Y Einav; I Goldberg; I Barshack; R Seijffers; J Kopolovic; N Kaiser; A Karasik
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

7.  The PDX-1 activation domain provides specific functions necessary for transcriptional stimulation in pancreatic beta-cells.

Authors:  M Peshavaria; M A Cissell; E Henderson; H V Petersen; R Stein
Journal:  Mol Endocrinol       Date:  2000-12

8.  High glucose is necessary for complete maturation of Pdx1-VP16-expressing hepatic cells into functional insulin-producing cells.

Authors:  Li-Zhen Cao; Dong-Qi Tang; Marko E Horb; Shi-Wu Li; Li-Jun Yang
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

9.  Ectopically expressed PDX-1 in liver initiates endocrine and exocrine pancreas differentiation but causes dysmorphogenesis.

Authors:  T Miyatsuka; H Kaneto; Y Kajimoto; S Hirota; Y Arakawa; Y Fujitani; Y Umayahara; H Watada; Y Yamasaki; M A Magnuson; J Miyazaki; M Hori
Journal:  Biochem Biophys Res Commun       Date:  2003-10-24       Impact factor: 3.575

Review 10.  Isolation, culture, and transplantation of rat hepatocytic precursor (stem-like) cells.

Authors:  J W Grisham; W B Coleman; G J Smith
Journal:  Proc Soc Exp Biol Med       Date:  1993-12
View more
  29 in total

1.  Krüppel-like Factor 7 engineered for transcriptional activation promotes axon regeneration in the adult corticospinal tract.

Authors:  Murray G Blackmore; Zimei Wang; Jessica K Lerch; Dario Motti; Yi Ping Zhang; Christopher B Shields; Jae K Lee; Jeffrey L Goldberg; Vance P Lemmon; John L Bixby
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-23       Impact factor: 11.205

2.  Pancreatic and duodenal homeobox gene 1 (Pdx1) down-regulates hepatic transcription factor 1 alpha (HNF1α) expression during reprogramming of human hepatic cells into insulin-producing cells.

Authors:  William Donelan; Shiwu Li; Hai Wang; Shun Lu; Chao Xie; Dongqi Tang; Lung-Ji Chang; Li-Jun Yang
Journal:  Am J Transl Res       Date:  2015-06-15       Impact factor: 4.060

3.  Differential ability of Ptf1a and Ptf1a-VP16 to convert stomach, duodenum and liver to pancreas.

Authors:  Zeina H Jarikji; Sandeep Vanamala; Caroline W Beck; Chris V E Wright; Steven D Leach; Marko E Horb
Journal:  Dev Biol       Date:  2007-01-25       Impact factor: 3.582

Review 4.  Genetic modification of stem cells for transplantation.

Authors:  M Ian Phillips; Yao Liang Tang
Journal:  Adv Drug Deliv Rev       Date:  2007-10-11       Impact factor: 15.470

Review 5.  Stages based molecular mechanisms for generating cholangiocytes from liver stem/progenitor cells.

Authors:  Wei-Hui Liu; Li-Na Ren; Tao Chen; Li-Ye Liu; Li-Jun Tang
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

Review 6.  Present and future cell therapies for pancreatic beta cell replenishment.

Authors:  Juan Domínguez-Bendala; Camillo Ricordi
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

7.  Epimorphin regulates bile duct formation via effects on mitosis orientation in rat liver epithelial stem-like cells.

Authors:  Junnian Zhou; Lei Zhao; Lipeng Qin; Jing Wang; Yali Jia; Hailei Yao; Chen Sang; Qinghua Hu; Shuangshuang Shi; Xue Nan; Wen Yue; Fengyuan Zhuang; Chun Yang; Yunfang Wang; Xuetao Pei
Journal:  PLoS One       Date:  2010-03-17       Impact factor: 3.240

Review 8.  Promoting ectopic pancreatic fates: pancreas development and future diabetes therapies.

Authors:  E J Pearl; M E Horb
Journal:  Clin Genet       Date:  2008-09-09       Impact factor: 4.438

9.  Pdx-1 or Pdx-1-VP16 protein transduction induces beta-cell gene expression in liver-stem WB cells.

Authors:  Juliette Cuvelier Delisle; Lionel Martignat; Laurence Dubreil; Pierre Saï; Jean-Marie Bach; Vanessa Louzier; Steffi Bösch
Journal:  BMC Res Notes       Date:  2009-01-09

Review 10.  Stem cells in the adult pancreas and liver.

Authors:  Zoë D Burke; Shifaan Thowfeequ; Macarena Peran; David Tosh
Journal:  Biochem J       Date:  2007-06-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.